Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

NewLink Genetics Corp (NASDAQ:NLNK)

During the Trading Day
51.83 +0.91 / +1.79%
As of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
51.83 0.00 / 0.00%
 
Volume: 16.6K

Today’s Trading

Previous close50.92
Today’s open50.97
Day’s range50.16 - 52.06
Volume347,647
Average volume (3 months)575,216
Market cap$1.5B
Dividend yield--
Data as of 3:59pm ET, 08/04/2015

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-146.54%
Earnings growth (next 5 years)--
Revenue growth (last year)+15,690.67%
P/E ratio13.5
Price/Sales7.15
Price/Book6.64

Competitors

 Today’s
change
Today’s
% change
ZSPHZS Pharma Inc+2.68+4.43%
IRWDIronwood Pharmaceuti...+0.08+0.76%
EGRXEagle Pharmaceutical...+2.97+3.09%
FWPForward Pharma A/S+0.28+0.86%
Data as of 3:59pm ET, 08/04/2015

Financials

Next reporting dateOctober 28, 2015
EPS forecast (this quarter)-$0.77
Annual revenue (last year)$172.6M
Annual profit (last year)$102.9M
Net profit margin59.60%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, Chief Executive &
Scientific Officer
Charles J. Link
President &
Chief Medical Officer
Nicholas N. Vahanian
Corporate headquarters
Ames, Iowa

Forecasts